Delivery Order SPE2DB24D2012-SPE2DB24FBVJA
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, worth $15,229.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a medical product, with a completion date of April 5, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $13,500.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a performance period ending on January 21, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,850.93, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This federal contract award is a Delivery Order valued at $7,001.95 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a prescription medication, with a period of performance through May 16, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,649.65, is a Delivery Order for the supply of OTEZLA 30 MG TABLET 60S. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $71,808.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a completion date of February 26, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,287.85, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 28, 2023 and is a Firm Fixed Price agreement. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $83,556.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 19, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,635.71 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This contract award, valued at $7,754.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of November 27, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract award is not designated as a set-aside. AmerisourceBergen holds a significant...